glp 1 drugs and alcohol Frontiers GLP-1s Hold Promise as Treatment

For people already living with diabetes, treatment aims at an individualised HbA1c target commonly below 7% for many adults, though this is adjusted for age, overall health, and the risk of low blood sugar [8]

The beneficial effects of GLP-1 receptor activation on glycemia occur through several mechanisms: GLP-1 stimulates glucose-dependent insulin secretion from pancreatic -cells, suppresses inappropriately elevated glucagon secretion from pancreatic -cells, delays gastric emptying, and induces satiety via a direct action in the central nervous system

Liraglutide slows down and sometimes even inhibits tumor growth of cancers in mice in in vivo studies

No needles, no syringes, no injection technique to learn

Similarly, the LEADER trial with liraglutide showed a numerically higher, though non-significant, rate of diabetic retinopathy events compared to placebo (HR, 1.15